Estimated time to complete activity: 1 hour
Date of initial release: February 18, 2014
Valid for CPE/CME/CE credit through: February 18, 2015
This educational program is designed for medical oncologists, hematologists, oncology nurses, advanced practice nurses, oncology/hematology nurse practitioners, physician assistants, and oncology/hematology pharmacists who participate in the management of patients with hematologic malignancies.
Upon completion of this activity, the participant will be able to:
- Discuss emerging data and recent advances in the personalized treatment of patients with hematologic malignancies, and integrate key findings into clinical practice
- Outline contemporary prognostic and predictive biomarkers and patient characteristics for MM, CLL, NHL, HL, MDS, and MF and apply the results to create an individualized approach to managing each patient